$AERT
Aeries Technology, Inc.

2023 Q2 Form 10-Q Financial Statement

#000119312523212708 Filed on August 15, 2023

View on sec.gov

Income Statement

Concept 2023 Q2
Revenue $0.00
YoY Change
Cost Of Revenue $11.88M
YoY Change
Gross Profit $4.447M
YoY Change
Gross Profit Margin
Selling, General & Admin $1.476M
YoY Change 400.79%
% of Gross Profit 33.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $327.0K
YoY Change
% of Gross Profit 7.35%
Operating Expenses $1.476M
YoY Change 400.79%
Operating Profit -$1.476M
YoY Change 400.79%
Interest Expense $3.509M
YoY Change -45.76%
% of Operating Profit
Other Income/Expense, Net -$6.000K
YoY Change
Pretax Income $2.033M
YoY Change -67.07%
Income Tax $218.0K
% Of Pretax Income 10.72%
Net Earnings $2.033M
YoY Change -67.07%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.16
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $41.84K
YoY Change -69.78%
Cash & Equivalents $41.84K
Short-Term Investments
Other Short-Term Assets $3.336K
YoY Change -99.2%
Inventory
Prepaid Expenses $152.9K
Receivables $13.76M
Other Receivables $0.00
Total Short-Term Assets $198.1K
YoY Change -64.42%
LONG-TERM ASSETS
Property, Plant & Equipment $10.10M
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $49.36M
YoY Change -78.77%
Other Assets $4.226M
YoY Change 3570.86%
Total Long-Term Assets $49.36M
YoY Change -78.78%
TOTAL ASSETS
Total Short-Term Assets $198.1K
Total Long-Term Assets $49.36M
Total Assets $49.56M
YoY Change -78.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.774M
YoY Change 36485.11%
Accrued Expenses $68.55K
YoY Change -76.91%
Deferred Revenue
YoY Change
Short-Term Debt $548.4K
YoY Change 171.54%
Long-Term Debt Due $12.00K
YoY Change
Total Short-Term Liabilities $7.938M
YoY Change 1442.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $446.8K
YoY Change -95.61%
Total Long-Term Liabilities $446.8K
YoY Change -95.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.938M
Total Long-Term Liabilities $446.8K
Total Liabilities $8.385M
YoY Change -21.5%
SHAREHOLDERS EQUITY
Retained Earnings -$8.087M
YoY Change -18.39%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$8.087M
YoY Change
Total Liabilities & Shareholders Equity $49.56M
YoY Change -78.74%

Cashflow Statement

Concept 2023 Q2
OPERATING ACTIVITIES
Net Income $2.033M
YoY Change -67.07%
Depreciation, Depletion And Amortization $327.0K
YoY Change
Cash From Operating Activities -$79.90K
YoY Change -41.49%
INVESTING ACTIVITIES
Capital Expenditures $258.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $189.4M
YoY Change
Cash From Investing Activities $189.4M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -189.3M
YoY Change -946723.0%
NET CHANGE
Cash From Operating Activities -79.90K
Cash From Investing Activities 189.4M
Cash From Financing Activities -189.3M
Net Change In Cash 30.10K
YoY Change -125.82%
FREE CASH FLOW
Cash From Operating Activities -$79.90K
Capital Expenditures $258.0K
Free Cash Flow -$337.9K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001853044
dei Entity Address Address Line1
EntityAddressAddressLine1
770 E Technology Way F13-16
dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40920
dei Entity Registrant Name
EntityRegistrantName
WORLDWIDE WEBB ACQUISITION CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1587626
dei Entity Address City Or Town
EntityAddressCityOrTown
OREM
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84097
dei City Area Code
CityAreaCode
415
dei Local Phone Number
LocalPhoneNumber
629-9066
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2023Q2 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#DerivativeLiabilitiesNoncurrent
CY2022Q4 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#DerivativeLiabilitiesNoncurrent
us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Net Derivative Asset Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationNetDerivativeAssetLiabilityGainLossStatementOfIncomeExtensibleList
http://fasb.org/us-gaap/2023#DerivativeLiabilitiesNoncurrent
CY2023Q2 us-gaap Cash
Cash
41844
CY2022Q4 us-gaap Cash
Cash
48126
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
152906
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
304314
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
3336
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
8334
CY2023Q2 us-gaap Assets Current
AssetsCurrent
198086
CY2022Q4 us-gaap Assets Current
AssetsCurrent
360774
CY2023Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
49362200
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
234716046
CY2023Q2 us-gaap Assets
Assets
49560286
CY2022Q4 us-gaap Assets
Assets
235076820
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5773862
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
676652
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1547171
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3091220
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
68554
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42267
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7938000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4010139
CY2023Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
446760
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
614040
CY2023Q2 wwacu Deferred Legal Fees Non Current
DeferredLegalFeesNonCurrent
0
CY2022Q4 wwacu Deferred Legal Fees Non Current
DeferredLegalFeesNonCurrent
343437
CY2023Q2 us-gaap Liabilities
Liabilities
8384760
CY2022Q4 us-gaap Liabilities
Liabilities
4967616
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.44
CY2022Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.2
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8087249
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4507417
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-8086674
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4506842
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
49560286
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
235076820
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1475740
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
294683
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3747112
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
657321
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1475740
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-294683
us-gaap Operating Income Loss
OperatingIncomeLoss
-3747112
us-gaap Operating Income Loss
OperatingIncomeLoss
-657321
CY2023Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1797240
CY2022Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6385200
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-167280
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10467240
CY2023Q2 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
1711537
CY2022Q2 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
83875
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
4080757
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
164227
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2033037
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
6174392
us-gaap Net Income Loss
NetIncomeLoss
500925
us-gaap Net Income Loss
NetIncomeLoss
9974146
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4506842
CY2023Q1 wwacu Accretion Of Classa Ordinary Shares To Redemption Value
AccretionOfClassaOrdinarySharesToRedemptionValue
2369220
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-1532112
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-8408174
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
0
CY2023Q2 wwacu Accretion Of Classa Ordinary Shares To Redemption Value
AccretionOfClassaOrdinarySharesToRedemptionValue
1711537
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2033037
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-8086674
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-19798051
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
3799755
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-15998296
CY2022Q2 wwacu Accretion Of Classa Ordinary Shares To Redemption Value
AccretionOfClassaOrdinarySharesToRedemptionValue
85071
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
6174392
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-9908975
us-gaap Net Income Loss
NetIncomeLoss
500925
us-gaap Net Income Loss
NetIncomeLoss
9974146
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
4080757
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
164227
wwacu Formation Costs And Operating Expenses Funded By Note Payable Through Sponsor
FormationCostsAndOperatingExpensesFundedByNotePayableThroughSponsor
78413
wwacu Formation Costs And Operating Expenses Funded By Note Payable Through Sponsor
FormationCostsAndOperatingExpensesFundedByNotePayableThroughSponsor
-6499
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-167280
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10467240
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-156406
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-169552
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5097210
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
12972
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1517762
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
116532
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
67155
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-364764
wwacu Trust Account Wthdrawal For Class A Share Redemptions
TrustAccountWthdrawalForClassAShareRedemptions
189434603
wwacu Trust Account Wthdrawal For Class A Share Redemptions
TrustAccountWthdrawalForClassAShareRedemptions
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
189434603
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
189434603
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
270000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
343437
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-189508040
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6282
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-364764
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48126
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
503204
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41844
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
138440
wwacu Accretion Of Classa Ordinary Shares To Redemption Value
AccretionOfClassaOrdinarySharesToRedemptionValue
4080757
wwacu Accretion Of Classa Ordinary Shares To Redemption Value
AccretionOfClassaOrdinarySharesToRedemptionValue
85071
wwacu Offering Costs Paid Through Promissory Note Related Party
OfferingCostsPaidThroughPromissoryNoteRelatedParty
0
wwacu Offering Costs Paid Through Promissory Note Related Party
OfferingCostsPaidThroughPromissoryNoteRelatedParty
201962
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2021-03-05
CY2021Q4 wwacu Offering Costs
OfferingCosts
21834402
CY2021Q4 wwacu Deferred Underwriting Fees Payable Non Current
DeferredUnderwritingFeesPayableNonCurrent
8050000
CY2021Q4 wwacu Underwriting Fees
UnderwritingFees
4600000
CY2021Q4 wwacu Other Offering Costs
OtherOfferingCosts
9184402
CY2021Q4 wwacu Offering Costs On Founder Shares Offered To Anchor Investors
OfferingCostsOnFounderSharesOfferedToAnchorInvestors
8306250
CY2021Q4 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
232300000
CY2021Q4 wwacu Deferred Underwriting Fees Payable Non Current
DeferredUnderwritingFeesPayableNonCurrent
8050000
CY2023Q2 wwacu Redemption Limitation Threshold Minimum Amount
RedemptionLimitationThresholdMinimumAmount
5000001
wwacu Period Within Which Business Combination Shall Be Consummated From The Closing Of Initia Public Offer
PeriodWithinWhichBusinessCombinationShallBeConsummatedFromTheClosingOfInitiaPublicOffer
P24M
CY2023Q2 us-gaap Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities
LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities
100000
CY2023Q2 us-gaap Cash
Cash
41844
CY2023Q2 wwacu Net Working Capital
NetWorkingCapital
7739914
CY2022 wwacu Percentage Of Fair Market Value Of Shares Repurchased
PercentageOfFairMarketValueOfSharesRepurchased
0.01
us-gaap Dilutive Securities
DilutiveSecurities
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 wwacu Percentage Of Common Stock Outstanding
PercentageOfCommonStockOutstanding
0.20
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style:italic;display:inline;">Use of Estimates</div> </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates </div>
CY2023Q2 us-gaap Cash
Cash
41844
CY2022Q4 us-gaap Cash
Cash
48126
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
us-gaap Derivatives Methods Of Accounting Nonhedging Derivatives
DerivativesMethodsOfAccountingNonhedgingDerivatives
<div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style:italic;display:inline;">Derivative Financial Instruments</div> </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company accounts for the Warrants, Forward Purchase Agreement (as defined below), and Working Capital Loan conversion option (collectively, the “Instruments”) in accordance with the guidance contained in ASC 815-40 under which the Instruments do not meet the criteria for equity treatment and must be recorded as liabilities. The conversion feature within the Working Capital Loan gives the Sponsor an option to convert the loan to warrants of the Company’s Class A ordinary shares. This bifurcated feature is assessed at the end of each reporting period to conclude whether additional liability should be recorded. The Instruments are subjected to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. See Note 5 and 7 for further discussion of the pertinent terms of the Warrants and Forward Purchase Agreement and Note 8 for further discussion of the methodology used to determine the value of the Warrants, Forward Purchase Agreement, and Working Capital Loan conversion option. </div>
CY2023Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
49362200
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
234716046
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
232300000
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2316046
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
234616046
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
4080757
wwacu Temporary Equity Stock Redeemed During Period Value
TemporaryEquityStockRedeemedDuringPeriodValue
-189434603
CY2023Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
49262200
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><div style="font-style:italic;display:inline;">Concentrations of Credit Risk</div> </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times may exceed the Federal depository insurance coverage of $250,000. At June 30, 2023 and December 31, 2022, the Company had not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. </div>
CY2023Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2023Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 wwacu Related Party Transaction Administrative Service Fee Payable Maximum Threshold Limit
RelatedPartyTransactionAdministrativeServiceFeePayableMaximumThresholdLimit
160000
CY2023Q1 wwacu Related Party Transaction Administrative Service Fee Payable Maximum Threshold Limit
RelatedPartyTransactionAdministrativeServiceFeePayableMaximumThresholdLimit
160000
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
180361
CY2021Q4 wwacu Related Party Transaction Administrative Service Fee Payable Maximum Threshold Limit
RelatedPartyTransactionAdministrativeServiceFeePayableMaximumThresholdLimit
160000
CY2023Q1 wwacu Related Party Transaction Administrative Service Fee Payable Maximum Threshold Limit
RelatedPartyTransactionAdministrativeServiceFeePayableMaximumThresholdLimit
160000
wwacu Deferred Underwriting Fee Percent On Gross Proceeds Of The Ipo
DeferredUnderwritingFeePercentOnGrossProceedsOfTheIpo
3.5
CY2023Q2 wwacu Deferred Underwriting Discount
DeferredUnderwritingDiscount
8050000
wwacu Overallotmentoptionvestingperiod
Overallotmentoptionvestingperiod
P45D
wwacu Deferred Underwriting Fees Waived
DeferredUnderwritingFeesWaived
8050000
wwacu Gain On Settlement Of Underwriting Fees
GainOnSettlementOfUnderwritingFees
202548
CY2021Q3 wwacu Class Of Warrant Or Right Issued During Period Warrants
ClassOfWarrantOrRightIssuedDuringPeriodWarrants
20400000
CY2021Q3 wwacu Class Of Warrant Or Right Redemption Threshold Consecutive Trading Days
ClassOfWarrantOrRightRedemptionThresholdConsecutiveTradingDays
P30D
CY2021Q3 wwacu Class Of Warrant Or Right Threshold Period For Exercise From Date Of Closing Public Offering
ClassOfWarrantOrRightThresholdPeriodForExerciseFromDateOfClosingPublicOffering
P12M
wwacu Class Of Warrant Or Right Redemption Threshold Consecutive Trading Days
ClassOfWarrantOrRightRedemptionThresholdConsecutiveTradingDays
P30D
wwacu Class Of Warrant Or Right Threshold Period For Exercise From Date Of Closing Public Offering
ClassOfWarrantOrRightThresholdPeriodForExerciseFromDateOfClosingPublicOffering
P12M
wwacu Number Of Business Day After The Closing Of The Initial Business Combination For Registration
NumberOfBusinessDayAfterTheClosingOfTheInitialBusinessCombinationForRegistration
P15D
CY2023Q2 wwacu Class Of Warrants Redemption Price Per Unit
ClassOfWarrantsRedemptionPricePerUnit
0.1
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
446760
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
614040
CY2023Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Net
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersNet
0
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Transfers Net
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationTransfersNet
0
CY2022Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
614040
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
-167280
CY2023Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
446760

Files In Submission

Name View Source Status
0001193125-23-212708-index-headers.html Edgar Link pending
0001193125-23-212708-index.html Edgar Link pending
0001193125-23-212708.txt Edgar Link pending
0001193125-23-212708-xbrl.zip Edgar Link pending
d506441d10q.htm Edgar Link pending
d506441dex311.htm Edgar Link pending
d506441dex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wwacu-20230630.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
wwacu-20230630_cal.xml Edgar Link unprocessable
wwacu-20230630_lab.xml Edgar Link unprocessable
wwacu-20230630_def.xml Edgar Link unprocessable
wwacu-20230630_pre.xml Edgar Link unprocessable
d506441d10q_htm.xml Edgar Link completed